Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

11 March 2002

Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.

Izabela Iwan-Zietek, Anna Wankiewicz, Maria Kotschy, Zenon Gwieździński

Med Sci Monit 2002; 8(3): CR189-192 :: ID: 420904

Abstract

BACKGROUND: Dermatitis herpetiformis (DH) is a very rare bullous dermatitisof autoimmune origin. It is a syndrome involving dermal and intestinal pathology, in which vesicopapularskin lesions are accompanied by gluten-dependent enteropathy. The diagnosis of DH is based on immunopathologicalinvestigation of unaffected skin bioptate (presence of granular IgA deposits in the upper portions ofdermal papillae). MATERIAL/METHODS: The study was carried out in a group of 33 patients, including 23males and 10 females aged 22-78 (mean age 44.7 years). The following fibrinolysis system parameters weredetermined in the sera of all patients: tissue plasminogen activator concentration (t-PA: Ag), urokinaseplasminogen activator concentration (u-PA: Ag), plasminogen activator inhibitor concentration (PAI-Ag),plasminogen level, alpha-2 antiplasmin activity (alpha-2-AP), plasmin-- alpha-2 antiplasmin complexesconcentration (PAP). RESULTS: Mean t-PA concentration in DH patients was 5.52 ng/ml, vs. 4.8 ng/ml incontrols. The respective u-PA concentrations amounted to 0.33 ng/ml, and 0.39 ng/ml. PAI-1 concentrationwas markedly higher in DH patients (36.2 ng/ml) than in controls (22.40 ng/ml), whereas plasminogen levelwas significantly lower (86.0% vs. 115.9%). In patients, alpha-2-AP activity was 92% and was lower thanin controls -103.4%. DH patients demonstrated also higher concentrations of PAP complexes (327.45 ng/ml)than the control group (203.03 ng/ml). CONCLUSIONS: Patients with DH were found to have lower plasminogenand alpha-2 antiplasmin levels and increased concentrations of PAP complexes, which indicates increasedplasminogenesis in vivo. Increased type 1 plasminogen activator inhibitor level (PAI-1) may reflect achronic inflammatory condition present in DH patients.

Keywords: Antiplasmin, Autoimmune Diseases, dermatitis herpetiformis, Fibrinolysis, Immunoglobulin A, Plasminogen, Plasminogen Inactivators, Sex Factors, Tissue Plasminogen Activator, Urinary Plasminogen Activator

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750